The efficacy of Henna cream in preventing of Radiation induced dermatitis

Effect of Henna cream ( Lawsonia inermis L) in preventing and reducing the severity of Radiation induced dermatitis in patients with breast cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191107045357N1

Enrollment

Registered

2020-05-07

Start date

2019-11-16

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation induced dermatitis. Acute radiodermatitis

Interventions

Intervention 1: Intervention group: Cream contains 10% henna: From the beginning day of radiotherapy, patients will apply a thin layer of the cream topically to the irradiated areas, twice a day, once

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with breast cancer who had breast conservative surgery

Exclusion criteria

Exclusion criteria: Collagen vascular diseases Skin diseases Hypersensitivity to Henna Smoking Diabetes mellitus Chronic renal failure Concurrent chemotherapy History of chest wall irradiation History of severe reaction to topical medication Inflammatory breast cancer Radical mastectomy

Design outcomes

Primary

Measure	Time frame
Grade of dermatitis. Timepoint: Weekly during radiotherapy. Method of measurement: RTOG Grading Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansour Lesan

Shahid Beheshti University of Medical Sciences

mansourlesan@sbmu.ac.ir009873432610

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026